Effect of Surfactant Therapy Using Orogastric Tube for Tracheal Catheterization in Preterm Newborns with Respiratory Distress
- 474 Downloads
To assess the outcome of a modified method of Minimally Invasive Surfactant Therapy (MIST) therapy where an orogastric tube was used for tracheal catherization to deliver surfactant in preterm newborns less than 34 wk of gestation with respiratory distress syndrome (RDS).
A single centre, prospective observational study was conducted to enroll eligible inborn preterm neonates with gestation age more than 24 wk but less than 34 wk and suffering from RDS to receive surfactant using MIST. Results were compared with a historical cohort of preterms who received surfactant with InSurE (Intubate, Surfactant, Extubate) technique.
Sixty four cases in the modified MIST group were compared with a historic cohort of 68 cases in the InSurE group. There were no differences in the requirement of intubation and mechanical ventilation (MV) in the first 72 h but the duration of MV and continuous positive airway pressure (CPAP) were significantly less in modified MIST group. Other neonatal morbidities and mortality rates were similar in either of the groups.
The modified MIST technique is an effective method for the treatment of RDS in preterms with better clinical efficacy and comparable outcomes than the more invasive InSurE procedure and deserves further evaluation.
KeywordsInSurE Surfactant Preterm Minimal invasive surfactant therapy Respiratory distress
RPST: Coordinated patient management and drafted the initial report; RG & DY: Supervised management and critically reviewed the manuscript. All the authors approved the final version of the manuscript. RG will act as guarantor for the paper.
Compliance with Ethical Standards
Conflict of Interest
Source of Funding
- 2.Public Health Foundation of India. All India Institute of Medical Sciences, Save the Children. In: Zodpey S, Paul VK, editors. State of India’s Newborns (SOIN) 2014- A Report. New Delhi: PHFI, AIIMS, SC; 2014.Google Scholar
- 9.The International Classification of Retinopathy of Prematurity Revisited. The International Committee for the classification of retinopathy of prematurity. Arch Ophthalmol. 2005;123:991–9.Google Scholar
- 12.Göpel W, Kribs A, Ziegler A, et al; German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378:1627–34.Google Scholar
- 16.Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000;2:CD001456.Google Scholar
- 17.SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network; Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362:1970–9.Google Scholar
- 18.Dunn MS, Kaempf J, de Klerk A, et al; Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128:e1069–76.Google Scholar
- 19.Sandri F, Plavka R, Ancora G, et al; CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125:e1402–9.Google Scholar